Clinical Trials Directory

Trials / Unknown

UnknownNCT01754961

Effects of Vitamin D on Inflammation in Liver Disease

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Veterans Medical Research Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chronic liver diseases are associated with inflammation. The investigators postulate that Vitamin D may modulate inflammation. Thus the investigators will study the effect of Vitamin D replacement in patients with Hepatitis C infection and Vitamin D deficiency.

Detailed description

Vitamin D appears to be a critical signaling molecule for macrophages because is needed for activation and differentiation of monocytes/macrophages. From our Preliminary Studies( VA Merit Review Grant), we propose that Vitamin D deficiency may alter the 'pro-inflammatory' ('classically activated') M1 macrophages , characterized by i\] high expression of NOS2, TNF-a, IL-1, IL-6, IL-8, TGF-a, CXCL10, and CCL19; and ii\] minimal expression of arginase 1 and mannose R. The clinical relevance of these findings is suggested by the presence of activated M1 macrophages in liver biopsies from patients with severe drug-induced liver injury (unpublished observations). Prospective vitamin D supplementation studies with appropriate endpoints are needed to define the role of vitamin D on inflammation in patients with chronic liver diseases.

Conditions

Interventions

TypeNameDescription
DRUGVitamin DVitamin D 500,000 IU given orally on Day 1
DRUGPlaceboPlacebo given orally on Day 1

Timeline

Start date
2011-11-01
Primary completion
2013-10-01
Completion
2014-01-01
First posted
2012-12-21
Last updated
2012-12-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01754961. Inclusion in this directory is not an endorsement.